Non-Infectious Uveitis – What’s Best for my patient: Local or systemic treatment?

The COS is pleased to provide access to the presentations from the co-developed symposium Non-Infectious Uveitis: What’s Best For My Patient: Local or Systemic Treatment?, which took place at the 2018 COS Annual Meeting in Toronto, Ontario. Through these presentations, International and Canadian expert faculty lead a discussion around the various treatment strategies for uveitis, how to choose the most appropriate line of therapy for different uveitis presentations. A novel model of collaborative care between ophthalmology and rheumatology was also presented. Below, you will find a video of the presentation by each speaker.

CPD credits: Scanning resources that are relevant to your professional practice by enhancing your awareness of new evidence, perspectives and findings can be claimed as Section 2: Self-Learning under Scanning in MAINPORT with the MOC Program of the Royal College of Physicians and Surgeons of Canada.

Presentation 1: Use of Anti-VEGFs in Uveitis
Dr. Amin Kherani reviews the epidemiology and pathogenesis of VEGF, then explains the management of uveitis and the role of anti-VEGF therapy.

Presentation 2: Topical and Injected Corticosteroids: When are they appropriate?
Dr. Chloe Gottlieb discusses the appropriate use of topical and periocular steroids for treating uveitis, the steroid-related complications that limit this use, and the benefit of additional therapies.

Presentation 3: Intraocular Implants vs. Immunosuppression
Dr. Marc de Smet covers conventional uveitis medications, and compares immunosuppressive treatment options.

Presentation 4: Immunosuppression for Uveitis: What, when, how, and by whom
Dr. Larissa Derzko-Dzulynsky expands on the area of immunosuppression for uveitis, highlighting first line and second line treatments, including biologics. 

Presentation 5: Collaboration Between Ophthalmologists and Rheumatologists for Patients with Uveitis
Dr. Olga Ziouzina presents a collaborative care model for uveitis treatment, drawing from her own experience at a combined multidisciplinary uveitis clinic in Calgary.

Panel Discussion
At the end of the session, moderator and Chair, Dr. Eric Fortin leads the audience and faculty through a series of questions related to Non-Infectious Uveitis: What’s Best for my Patient: Local or Systemic Treatment?

In collaboration with the Canadian Ophthalmological Society, the Canadian Retina Society, and the Canadian Uveitis Society. This symposium was co-developed with AbbVie and was planned to achieve scientific integrity, objectivity and balance.

This resource is only available in English.

Dernier rappel : Appel de candidatures pour l’édition 2021 du prix Reconnaissance pour l’ensemble d’une carrière de la SCO Vous avez jusqu'au mercredi 30 septembre 2020 à 23 h 59, heure de l’Est, pour présenter une candidature. ow.ly/NLgI50BD2ak

Yesterday from Can Ophthal Society's Twitter via Hootsuite Inc.

Can Ophthal Society's Twitter via Twitter Web Client